Respiratory tract infections in primary care: narrative review of CRP point-of-care testing and antibacterial use
Published on
In our feature article series, we take a look at publications of particular relevance to point-of-care testing (POCT), providing summaries and expert commentary on the key aspects of the paper and within the wider context of POCT systems.In this article, we cover the below publication by Professor Cooke and co-authors
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
RESTRICTED
Published on
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) European Heart Journal 2020;42:255-323These guidelines provide direction on the management and prevention of cardiovascular disease (CVD) in subjects with, an...
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
RESTRICTED
Published on
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)European Heart Journal, 2020Publication of this update to the 2016 guidelines follows emergence of a substantial body of evidence pertaining to low-density lipoprotein-C (LDL-C) reductions and risk of atherosclerotic cardiovascular disease (ASCVD). Monitoring LDL-C for longer periods is now required, with new g...
Trueness assessment of HbA1c routine assays: are processed EQA materials up to the job?
RESTRICTED
Published on
Vincent Delatour, Noémie Clouet-Foraisona, Stéphane Jaisson, Patricia Kaiser and Philippe Gillery
Clinical Chemistry and Laboratory Medicine 2019;25(57)10:1623-1631
In this article Delatour and co-authors explore the trueness of external quality assessment (EQA) programmes for determining accuracy of HbA1c testing in diabetes (both lab-based and point-of-care systems). Commutability of processed EQA materials was found to be highly heterogeneou...
Investigating the quality of POCT devices for HbA1c: what are our next steps?
RESTRICTED
Published on
Erna Lenters-Westra and Emma English
Journal of Diabetes Science and Technology 2019;13(6):1154-1157
Lenters-Westra and English consider the pros and cons of different methods for evaluating the performance of HbA1c point-of-care testing (POCT) devices, including:
• CE marking for the European market
• Food and Drug Administration (FDA) clearance for the American market
• International Federation of Clinical Chemistry and Laboratory Medicine (...
CPD Certified
Access Now
By using this site, you agree with our use of cookies.
